These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells. Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Oh S; Jeong HG; Johnston RN; Assavalapsakul W; Chung YH Mol Med Rep; 2015 Mar; 11(3):2315-21. PubMed ID: 25395162 [TBL] [Abstract][Full Text] [Related]
4. Caged-xanthone from Cratoxylum formosum ssp. pruniflorum inhibits malignant cancer phenotypes in multidrug-resistant human A549 lung cancer cells through down-regulation of NF-κB. Kaewpiboon C; Boonnak N; Yawut N; Kaowinn S; Chung YH Bioorg Med Chem; 2019 Jun; 27(12):2368-2375. PubMed ID: 30606669 [TBL] [Abstract][Full Text] [Related]
5. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation. Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430 [TBL] [Abstract][Full Text] [Related]
6. Formoxanthone C, isolated from Cratoxylum formosum ssp. pruniflorum, reverses anticancer drug resistance by inducing both apoptosis and autophagy in human A549 lung cancer cells. Kaewpiboon C; Boonnak N; Kaowinn S; Chung YH Bioorg Med Chem Lett; 2018 Feb; 28(4):820-825. PubMed ID: 29402743 [TBL] [Abstract][Full Text] [Related]
7. Imatinib resistance in multidrug-resistant K562 human leukemic cells. Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528 [TBL] [Abstract][Full Text] [Related]
8. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line. Lin X; Zhang X; Wang Q; Li J; Zhang P; Zhao M; Li X Neoplasma; 2012; 59(3):248-56. PubMed ID: 22329846 [TBL] [Abstract][Full Text] [Related]
9. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091 [TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells. Tran TP; Kim HG; Choi JH; Na MK; Jeong HG Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342 [TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505 [TBL] [Abstract][Full Text] [Related]
12. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles. Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893 [TBL] [Abstract][Full Text] [Related]
13. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
14. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. Sun J; Yeung CA; Co NN; Tsang TY; Yau E; Luo K; Wu P; Wa JC; Fung KP; Kwok TT; Liu F PLoS One; 2012; 7(8):e40720. PubMed ID: 22927901 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism involved in the As2O3-regulated decrease in MDR1 expression in leukemia cells. Gao F; Liu J; Dong WW; Wang W; Wang Y; Cai D; Zheng Z; Sun K Oncol Rep; 2014 Feb; 31(2):926-32. PubMed ID: 24337533 [TBL] [Abstract][Full Text] [Related]
16. Nuclear Transcription Factor Kappa B Downregulation Reduces Chemoresistance in Bone Marrow-derived Cells Through P-glycoprotein Modulation. Loaiza B; Hernández-Gutierrez S; Montesinos JJ; Valverde M; Rojas E Arch Med Res; 2016 Feb; 47(2):78-88. PubMed ID: 27259382 [TBL] [Abstract][Full Text] [Related]
17. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells. Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586 [TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122 [TBL] [Abstract][Full Text] [Related]
20. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Mendoza FJ; Ishdorj G; Hu X; Gibson SB Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]